JP4071837B2 - Reagent composition for detecting ascorbic acid and test piece - Google Patents

Reagent composition for detecting ascorbic acid and test piece Download PDF

Info

Publication number
JP4071837B2
JP4071837B2 JP20635496A JP20635496A JP4071837B2 JP 4071837 B2 JP4071837 B2 JP 4071837B2 JP 20635496 A JP20635496 A JP 20635496A JP 20635496 A JP20635496 A JP 20635496A JP 4071837 B2 JP4071837 B2 JP 4071837B2
Authority
JP
Japan
Prior art keywords
ascorbic acid
iron
composition
iii
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP20635496A
Other languages
Japanese (ja)
Other versions
JPH1019874A (en
Inventor
敏久 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arkray Inc
Original Assignee
Arkray Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arkray Inc filed Critical Arkray Inc
Priority to JP20635496A priority Critical patent/JP4071837B2/en
Publication of JPH1019874A publication Critical patent/JPH1019874A/en
Application granted granted Critical
Publication of JP4071837B2 publication Critical patent/JP4071837B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【0001】
【発明の属する技術分野】
本発明は、液体試料中の、さらに詳しくは、全血、血清、血漿、尿、髄液、唾液などの生体試料中のアスコルビン酸を検出するための試薬組成物及び試験片に関する。
【0002】
【従来の技術】
液体試料中のアスコルビン酸を検出するための方法は、種々存在し、知られている。
例えば、特開昭55−142249号には、キレート剤と鉄(III)イオン(又は銅(II)イオン)との錯体、金属指示薬、緩衝剤などを用いた方法が示されている。
また、特開昭57−154056号、特開昭58−63850号、特開昭60−162954号、特開平1−259260号には、インドフェノール系色素を用いた方法が示されている。
また、特開昭54−80793号、特開昭59−106476号、特開平1−213574号には、テトラゾリウム系色素を用いた方法が示されている。
また、特開昭54−30890号には、オキサジン系色素を用いた方法が示されている。
また、特開昭48−100187号、特開昭56−8550号には、モリブデン酸を用いた方法が示されている。
また、特開昭60−6870号には、銅イオンを用いて、アスコルビン酸が酸化されて出る過酸化水素による検出を用いた方法が示されている。
【0003】
【発明が解決しようとする課題】
最近の尿試験片、例えばグルコース、潜血などの項目においては、尿中のアスコルビン酸等還元性物質の影響をある程度の濃度までは、回避できるように工夫されてきているが、充分なものではなく、還元性物質を検出するために、測定レンジが広い試験片が必要となってきている。
しかし、上記の従来技術では、100mg/dl程度までのアスコルビン酸しか検出できないという課題があった。
【0004】
【課題を解決するための手段】
本発明は、上記課題を解決するために、液体試料中のアスコルビン酸を検出するための試薬組成物において、
(i)鉄(III)化合物、
(ii)鉄(II)イオン検出試薬、
(iii)酸化剤
を含み、かつ
酸化剤がヨウ素酸塩であることを特徴とするアスコルビン酸検出用組成物である。
また、液体試料中のアスコルビン酸を検出するための試験片において、上記の試薬組成物を保持体に保持することを特徴とする試験片である。
【0005】
【発明の実施の形態】
本発明は、さらに、緩衝剤を含むことが好ましい。
緩衝剤は、リン酸緩衝液、酢酸緩衝液、マロン酸緩衝液、クエン酸緩衝液など種々用いることができる。
また、緩衝剤のpHは、2〜7であることが好ましい。
【0006】
さらに、本発明には、ポリマーや界面活性剤を含むことができる。
ポリマーは、ヒドロキシプロピルセルロース、ポリビニルピロリドン、ポリビニルアルコール、アルギン酸ナトリウム、ポリアクリル酸ナトリウム、ゼラチンなど種々用いることができる。
界面活性剤は、ポリオキシエチレンオクチルフェニルエーテル(トリトンX−100)、ポリオキシエチレンソルビタンモノラウレート(ツイーン20)、ポリオキシエチレンソルビタンモノステアレート(ツイーン60)、ポリオキシエチレンラウリルエーテル(ブリッジ35)、ポリオキシエチレンセチルエーテル(ブリッジ58)など種々用いることができる。
【0007】
本発明における鉄(III)化合物は、エチレンジアミン四酢酸一ナトリウム鉄(III)、シュウ酸アンモニュウム鉄(III)水和物、硫酸鉄(III)アンモニュウム水和物、塩化鉄(III)等のキレート化合物やイオン化合物から選択することができる。
【0008】
また、鉄(II)イオン検出試薬は、2,2’−ビピリジン、2,2’−ビキノリン、1,10−フェナントトリン等の化合物や誘導体から選択することができる。
【0009】
また、酸化剤は、ヨウ素酸ナトリウム、ヨウ素酸カリウムなどのヨウ素酸塩であるが、ヨウ素酸ナトリウムが好ましい。
本発明は、さらに、液体試料中のアスコルビン酸を検出するための液状試薬や錠剤試薬に応用することも可能である。
以下に実施例を示すが、本発明はこれに限定されるものではない。
【0010】
【実施例1】
濾紙(ワットマン社製;3MMChr)を、下記に示す試薬含浸液に含浸、乾燥した。
<処方>
2,2’−ビピリジン(ナカライテスク製) 3 g
エチレンジアミン四酢酸鉄(III)−ナトリウム 4 g
(ナカライテスク製)
ヨウ素酸ナトリウム(ナカライテスク製) 1 g
ポリビニルピロリドンK−30(ナカライテスク製) 10 g
0.5Mクエン酸/クエン酸ナトリウム緩衝液(pH4) 80 ml
エタノール 20 ml
【0011】
【実施例2】
濾紙(ワットマン社製;3MMChr)を、下記に示す試薬含浸液に含浸、乾燥した。
<処方>
1,10−フェナントロリン(ナカライテスク製) 3 g
エチレンジアミン四酢酸鉄(III)−ナトリウム 4 g
(ナカライテスク製)
ヨウ素酸ナトリウム(ナカライテスク製) 1 g
ポリビニルピロリドンK−30(ナカライテスク製) 10 g
0.5Mクエン酸/クエン酸ナトリウム緩衝液(pH4) 80 ml
エタノール 20 ml
【0012】
【比較例1】
濾紙(ワットマン社製;3MMChr)を、下記に示す試薬含浸液に含浸、乾燥した。
<処方>
2,2’−ビピリジン(ナカライテスク製) 3 g
エチレンジアミン四酢酸鉄(III)一ナトリウム 4 g
(ナカライテスク製)
ポリビニルピロリドンK−30(ナカライテスク製) 10 g
0.5Mクエン酸/クエン酸ナトリウム緩衝液(pH4) 80 ml
エタノール 20 ml
【0013】
【比較例2】
濾紙(ワットマン社製;3MMChr)を、下記に示す試薬含浸液に含浸、乾燥した。
<処方>
1,10−フェナントロリン(ナカライテスク製) 3 g
エチレンジアミン四酢酸鉄(III)一ナトリウム 4 g
(ナカライテスク製)
ポリビニルピロリドンK−30(ナカライテスク製) 10 g
0.5Mクエン酸/クエン酸ナトリウム緩衝液(pH4) 80 ml
エタノール 20 ml
【0014】
実施例1、2及び比較例1、2にて作製したこの片面に両面テープ(ソニーケミカル製;T4000)を貼り、5mm×5mmにカットし、試薬部分を得た。これを5mm×60mmのPETフィルムの先端部に貼付し、試験片を得た。
<測定方法>
実施例1、2及び比較例1、2にて作製した上記試験片の試薬部分に下記試料1〜6を7μl滴下して、各試験紙の最大吸収波長における1分後の反射率変化を、色差計(日本分光製;Σ−90)を用いて、測定した。
試料1;蒸留水
試料2;アスコルビン酸水溶液 ( 10mg/l)
試料3;アスコルビン酸水溶液 ( 30mg/l)
試料4;アスコルビン酸水溶液 ( 50mg/l)
試料5;アスコルビン酸水溶液 (100mg/l)
試料6;アスコルビン酸水溶液 (300mg/l)
ここで、最大吸収波長は、実施例1及び比較例1においては540nm、実施例2及び比較例2においては510nmとなった。
<結果>
結果として、実施例と比較例の最大吸収波長における反射率変化をまとめ、表1に示す。
【0015】
【表1】

Figure 0004071837
上記結果より、実施例1、2による試験片は、比較例1、2による試験片に比べて、測定レンジはかなり広くなっている。
しかも、試薬部分の発色は、発色系であるため肉眼比色においても有利である。
【0016】
【発明の効果】
本発明によって、従来よりも広い測定レンジを持つ試験片を作製することが可能になった。[0001]
BACKGROUND OF THE INVENTION
The present invention, in a liquid sample, the detail is al, whole blood, serum, plasma, urine, spinal fluid, a reagent composition and a test strip for detecting ascorbic acid in biological samples such as saliva.
[0002]
[Prior art]
Method for detecting ascorbic acid in the liquid sample, various exist, are known.
For example, Japanese Patent Application Laid-Open No. 55-142249 discloses a method using a complex of a chelating agent and iron (III) ions (or copper (II) ions), a metal indicator, a buffering agent and the like.
JP-A-57-154056, JP-A-58-63850, JP-A-60-162955, and JP-A-1-259260 show methods using indophenol dyes.
JP-A-54-80793, JP-A-59-106476, and JP-A-1-213574 disclose a method using a tetrazolium dye.
JP-A-54-30890 discloses a method using an oxazine dye.
Japanese Patent Application Laid-Open Nos. 48-1000018 and 56-8550 disclose methods using molybdic acid.
Japanese Patent Laid-Open No. 60-6870 discloses a method using detection with hydrogen peroxide which is produced by oxidizing ascorbic acid using copper ions.
[0003]
[Problems to be solved by the invention]
In recent urine test specimens such as glucose and occult blood, it has been devised to avoid the effects of reducing substances such as ascorbic acid in urine to a certain level, but it is not sufficient. In order to detect a reducing substance, a test piece having a wide measurement range is required.
However, the above conventional technique has a problem that only ascorbic acid up to about 100 mg / dl can be detected.
[0004]
[Means for Solving the Problems]
To solve the above problems, the present invention provides a reagent composition for detecting ascorbic acid in a liquid sample.
(I) an iron (III) compound,
(Ii) an iron (II) ion detection reagent,
(Iii) an oxidizing agent only contains, and
The composition for detecting ascorbic acid, wherein the oxidizing agent is iodate .
Further, in the test piece for detecting ascorbic acid in the liquid sample, the test composition is characterized in that the reagent composition is held on a holding body.
[0005]
DETAILED DESCRIPTION OF THE INVENTION
The present invention preferably further includes a buffer.
Various buffers such as a phosphate buffer, an acetate buffer, a malonate buffer, and a citrate buffer can be used.
Moreover, it is preferable that pH of a buffering agent is 2-7.
[0006]
Further, the present invention can include a polymer and a surfactant.
Various polymers such as hydroxypropyl cellulose, polyvinyl pyrrolidone, polyvinyl alcohol, sodium alginate, sodium polyacrylate, gelatin and the like can be used.
Surfactants include polyoxyethylene octyl phenyl ether (Triton X-100), polyoxyethylene sorbitan monolaurate (Tween 20), polyoxyethylene sorbitan monostearate (Tween 60), polyoxyethylene lauryl ether (Bridge 35). ), Polyoxyethylene cetyl ether (bridge 58), and the like.
[0007]
The iron (III) compound in the present invention is a chelate compound such as ethylenediaminetetraacetic acid monosodium iron (III), ammonium oxalate iron (III) hydrate, iron (III) ammonium hydrate, iron (III) chloride, etc. Or an ionic compound.
[0008]
The iron (II) ion detection reagent can be selected from compounds and derivatives such as 2,2′-bipyridine, 2,2′-biquinoline, 1,10-phenanthrin.
[0009]
Further, the oxidizing agent is sodium iodate, although Ru iodate der, such as potassium iodate, sodium iodate is preferred.
The present invention can also be applied to liquid reagents and tablet reagents for detecting ascorbic acid in a liquid sample.
Examples are shown below, but the present invention is not limited thereto.
[0010]
[Example 1]
A filter paper (manufactured by Whatman; 3MMChr) was impregnated in the reagent impregnation solution shown below and dried.
<Prescription>
2,2'-bipyridine (manufactured by Nacalai Tesque) 3 g
Ethylenediaminetetraacetic acid iron (III) -sodium 4 g
(Nacalai Tesque)
Sodium iodate (manufactured by Nacalai Tesque) 1 g
Polyvinylpyrrolidone K-30 (manufactured by Nacalai Tesque) 10 g
0.5 M citrate / sodium citrate buffer (pH 4) 80 ml
Ethanol 20 ml
[0011]
[Example 2]
A filter paper (manufactured by Whatman; 3MMChr) was impregnated in the reagent impregnation solution shown below and dried.
<Prescription>
1,10-phenanthroline (manufactured by Nacalai Tesque) 3 g
Ethylenediaminetetraacetic acid iron (III) -sodium 4 g
(Nacalai Tesque)
Sodium iodate (manufactured by Nacalai Tesque) 1 g
Polyvinylpyrrolidone K-30 (manufactured by Nacalai Tesque) 10 g
0.5 M citrate / sodium citrate buffer (pH 4) 80 ml
Ethanol 20 ml
[0012]
[Comparative Example 1]
A filter paper (manufactured by Whatman; 3MMChr) was impregnated in the reagent impregnation solution shown below and dried.
<Prescription>
2,2'-bipyridine (manufactured by Nacalai Tesque) 3 g
Ethylenediaminetetraacetic acid iron (III) monosodium 4 g
(Nacalai Tesque)
Polyvinylpyrrolidone K-30 (manufactured by Nacalai Tesque) 10 g
0.5 M citrate / sodium citrate buffer (pH 4) 80 ml
Ethanol 20 ml
[0013]
[Comparative Example 2]
A filter paper (manufactured by Whatman; 3MMChr) was impregnated in the reagent impregnation solution shown below and dried.
<Prescription>
1,10-phenanthroline (manufactured by Nacalai Tesque) 3 g
Ethylenediaminetetraacetic acid iron (III) monosodium 4 g
(Nacalai Tesque)
Polyvinylpyrrolidone K-30 (manufactured by Nacalai Tesque) 10 g
0.5 M citrate / sodium citrate buffer (pH 4) 80 ml
Ethanol 20 ml
[0014]
A double-sided tape (manufactured by Sony Chemicals; T4000) was applied to one side produced in Examples 1 and 2 and Comparative Examples 1 and 2, and cut into 5 mm × 5 mm to obtain a reagent portion. This was stuck on the front-end | tip part of 5 mm x 60 mm PET film, and the test piece was obtained.
<Measurement method>
7 μl of the following samples 1 to 6 were dropped on the reagent portions of the test pieces prepared in Examples 1 and 2 and Comparative Examples 1 and 2, and the reflectance change after 1 minute at the maximum absorption wavelength of each test paper was Measurement was performed using a color difference meter (manufactured by JASCO; Σ-90).
Sample 1; Distilled water sample 2; Ascorbic acid aqueous solution (10 mg / l)
Sample 3; ascorbic acid aqueous solution (30 mg / l)
Sample 4: Ascorbic acid aqueous solution (50 mg / l)
Sample 5: Ascorbic acid aqueous solution (100 mg / l)
Sample 6: Ascorbic acid aqueous solution (300 mg / l)
Here, the maximum absorption wavelength was 540 nm in Example 1 and Comparative Example 1, and 510 nm in Example 2 and Comparative Example 2.
<Result>
As a result, the change in reflectance at the maximum absorption wavelength in Examples and Comparative Examples is summarized and shown in Table 1.
[0015]
[Table 1]
Figure 0004071837
From the above results, the measurement range of the test pieces according to Examples 1 and 2 is considerably wider than that of the test pieces according to Comparative Examples 1 and 2.
In addition, since the coloring of the reagent portion is a coloring system, it is advantageous also in the naked eye colorimetry.
[0016]
【The invention's effect】
The present invention makes it possible to produce a test piece having a wider measurement range than before.

Claims (8)

液体試料中のアスコルビン酸を検出するための試薬組成物において、
(i)鉄(III)化合物、
(ii)鉄(II)イオン検出試薬、
(iii)酸化剤
を含み、かつ
酸化剤がヨウ素酸塩であることを特徴とするアスコルビン酸検出用組成物。
In a reagent composition for detecting ascorbic acid in a liquid sample,
(I) an iron (III) compound,
(Ii) an iron (II) ion detection reagent,
(Iii) An ascorbic acid detection composition comprising an oxidizing agent, and the oxidizing agent is an iodate.
さらに、緩衝剤を含むことを特徴とする請求項1に記載のアスコルビン酸検出用組成物。  The composition for detecting ascorbic acid according to claim 1, further comprising a buffer. 緩衝剤のpHが、2〜7であることを特徴とする請求項2に記載のアスコルビン酸検出用組成物。  The composition for detecting ascorbic acid according to claim 2, wherein the pH of the buffer is 2 to 7. さらに、ポリマーを含むことを特徴とする請求項1〜3のいずれかに記載のアスコルビン酸検出用組成物。  Furthermore, a polymer is contained, The composition for ascorbic acid detection in any one of Claims 1-3 characterized by the above-mentioned. さらに、界面活性剤を含むことを特徴とする請求項1〜4のいずれかに記載のアスコルビン酸検出用組成物。  Furthermore, surfactant is included, The composition for an ascorbic acid detection in any one of Claims 1-4 characterized by the above-mentioned. 鉄(III)化合物が、エチレンジアミン四酢酸一ナトリウム鉄(III)、シュウ酸アンモニュウム鉄(III)水和物、硫酸鉄(III)アンモニュウム水和物、及び
塩化鉄(III)のキレート化合物又はイオン化合物から選ばれることを特徴とする請求項1に記載のアスコルビン酸検出用組成物。
Iron (III) compound is ethylenediaminetetraacetic acid monosodium iron (III), ammonium oxalate iron (III) hydrate, iron (III) ammonium sulfate hydrate, and chelate or ionic compound of iron (III) chloride The composition for detecting ascorbic acid according to claim 1, wherein the composition is selected from.
鉄(II)イオン検出試薬が、2,2′−ビピリン、2,2′−ビキノリン、1,10−フェナントロリン及びそれらの誘導体から選ばれることを特徴とする請求項1に記載のアスコルビン酸検出用組成物。Iron (II) ion detection reagent, 2,2' Bipiri di emissions, 2,2'-biquinoline, 1,10-phenanthroline and ascorbic acid according to claim 1, characterized in that selected derivatives thereof Detection composition. 液体試料中のアスコルビン酸を検出するための試験片において、請求項1〜7のいずれかの試薬組成物を保持体に保持することを特徴とする試験片。  A test piece for detecting ascorbic acid in a liquid sample, wherein the reagent composition according to claim 1 is held on a holding body.
JP20635496A 1996-07-02 1996-07-02 Reagent composition for detecting ascorbic acid and test piece Expired - Fee Related JP4071837B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20635496A JP4071837B2 (en) 1996-07-02 1996-07-02 Reagent composition for detecting ascorbic acid and test piece

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20635496A JP4071837B2 (en) 1996-07-02 1996-07-02 Reagent composition for detecting ascorbic acid and test piece

Publications (2)

Publication Number Publication Date
JPH1019874A JPH1019874A (en) 1998-01-23
JP4071837B2 true JP4071837B2 (en) 2008-04-02

Family

ID=16521933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20635496A Expired - Fee Related JP4071837B2 (en) 1996-07-02 1996-07-02 Reagent composition for detecting ascorbic acid and test piece

Country Status (1)

Country Link
JP (1) JP4071837B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5152130B2 (en) * 2009-09-08 2013-02-27 住友金属鉱山株式会社 Simple analysis method and inspection kit for iron contained in dust

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55142249A (en) * 1979-04-24 1980-11-06 Shionogi & Co Ltd Reduction type ascorbic acid detecting composition and test piece
DE3012368C2 (en) * 1980-03-29 1982-04-15 Boehringer Mannheim Gmbh, 6800 Mannheim Methods and diagnostic means for the detection of redox reactions
US5264348A (en) * 1991-05-13 1993-11-23 Miles Inc. Ascorbate interference-resistant composition, device and method of assaying for predetermined analyte

Also Published As

Publication number Publication date
JPH1019874A (en) 1998-01-23

Similar Documents

Publication Publication Date Title
CN1207393C (en) Reagent test strip for analyte determination
CA1139646A (en) Composition and test strip for colorimetric analysis of ascorbic acid
RU2002131152A (en) COMPOSITIONS OF STABILIZED TETRAZOLIUM REAGENT AND WAYS OF THEIR APPLICATION
JP3667370B2 (en) Method for measuring proteins in biological samples
JP3537507B2 (en) Creatinine detection method and detector
US7820449B2 (en) Test strip for creatinine determination
HU176045B (en) Diagnostical composition for determining uric acid
WO1992011524A2 (en) Reagent and methods for calcium determination
JP3217066B2 (en) Compositions useful for anaerobic determination of analytes
JP3524602B2 (en) Method for analyzing protein in urine and composition for measuring the same
JP4071837B2 (en) Reagent composition for detecting ascorbic acid and test piece
JPH11153602A (en) All-protein detecting method
JPH054031B2 (en)
JP2955443B2 (en) Analytical element and analyte detection method
JP3809484B2 (en) Test piece for measuring magnesium in body fluids
JPH11344490A (en) Method for measuring iron without causing interference, and reagent
US5223438A (en) Agent composition for detecting redox reaction
EP0811844B1 (en) Reagent composition, testing piece and assay kit
CA2125832A1 (en) Reagent composition and method for determining lithium
EP0592674B1 (en) Method of assaying metal present in biological specimen and reagent therefor
JPH05260994A (en) Detection of analyte in saliva using peroxide-peroxidase test system
Nelson et al. Simplified automated method for determination of urinary or serum uric acid, based on reduction of ferric-phenanthroline complex
JP3090503B2 (en) Method for measuring protein
JP3260020B2 (en) UIBC measurement reagent
JP4104393B2 (en) Method for quantifying specific components in biological sample and reagent for quantification

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040604

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040615

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20040625

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040804

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040901

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050119

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050325

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20050705

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20050706

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070423

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071116

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080118

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110125

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110125

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110125

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110125

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110125

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120125

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120125

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130125

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140125

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees